|
ATC |
1 Agents affecting nervous system and sensory organs
|
|
|
2 Agents affecting individual organs
|
21 Cardiovascular agents
|
22 Respiratory organ agents
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
26 Epidermides
|
261 Antimicrobial agents
|
2611 Chlorates
|
2612 Iodates
|
2613 Borates
|
2614 Peroxides
|
2615 Alcohols
|
D00137 Isopropyl alcohol (USP); Isopropanol (JP17)
D00068 Alcohol (USP); Anhydrous ethanol (JP17)
D04855 Ethanol for disinfection (JP17)
D06542 Ethanol (JP17)
D04732 Isopropanol and methylated alcohol
|
D08AX05
D08AX08 V03AB16 V03AZ01
D08AX08 V03AB16 V03AZ01
D08AX08 V03AB16 V03AZ01
|
2616 Medical soaps
|
2619 Others
|
262 Skin protectants
|
263 Suppurative dermatosis agents
|
264 Analgesics, anti-itchings, astringents, anti-inflammatory agents
|
265 Antiparasitic dermatosis agents
|
266 Emollients
|
267 Hair remedies
|
268 Bath preparations
|
269 Miscellaneous
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
|
3 Agents affecting metabolism
|
|
|
4 Agents affecting cellular function
|
41 Cellular function activating agents
|
42 Antineoplastics
|
421 Alkylating agents
|
422 Antimetabolites
|
423 Antibiotics
|
424 Plant extract preparations
|
429 Miscellaneous
|
4291 Other Antitumors
|
D00068 Alcohol (USP); Anhydrous ethanol (JP17)
D00094 Tretinoin (JAN/USP/INN)
D01370 Cladribine (JAN/USP/INN)
D03021 Azacitidine (JAN/USAN/INN)
D06199 Trabectedin (JAN/USAN/INN)
D02166 Mitoxantrone hydrochloride (JAN/USP)
D01441 Imatinib mesylate (USAN); Imatinib mesilate (JAN)
D06414 Dasatinib (USAN); Dasatinib hydrate (JAN)
D06413 Nilotinib hydrochloride hydrate (JAN)
D09728 Bosutinib hydrate (JAN)
D09951 Ponatinib hydrochloride (JAN/USAN)
D01977 Gefitinib (JAN/USAN/INN)
D04023 Erlotinib hydrochloride (JAN/USAN)
D09733 Afatinib dimaleate (USAN); Afatinib maleate (JAN)
D10766 Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)
D10514 Dacomitinib (USAN); Dacomitinib hydrate (JAN)
D09996 Vemurafenib (JAN/USAN/INN)
D10104 Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN)
D11053 Encorafenib (JAN/USAN/INN)
D09731 Crizotinib (JAN/USAN/INN)
D10551 Ceritinib (JAN/USAN/INN)
D10450 Alectinib hydrochloride (JAN)
D11012 Lorlatinib (JAN/USAN/INN)
D10176 Trametinib dimethyl sulfoxide (JAN/USAN)
D10604 Binimetinib (JAN/USAN)
D10372 Palbociclib (JAN/USAN)
D10688 Abemaciclib (JAN/USAN)
D06068 Temsirolimus (JAN/USAN/INN)
D02714 Everolimus (JAN/USAN/INN)
D04024 Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN)
D09960 Ruxolitinib phosphate (JAN/USAN)
D03218 Axitinib (JAN/USAN)
D10223 Ibrutinib (JAN/USAN)
D06402 Sunitinib malate (JAN/USAN)
D06272 Sorafenib tosylate (USAN); Sorafenib tosilate (JAN)
D05380 Pazopanib hydrochloride (JAN/USAN)
D06407 Vandetanib (JAN/USAN/INN)
D10137 Regorafenib hydrate (JAN)
D10095 Cabozantinib s-malate (USAN); Cabozantinib malate (JAN)
D09920 Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN)
D09956 Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN)
D10800 Gilteritinib fumarate (JAN/USAN)
D10926 Entrectinib (JAN/USAN/INN)
D10891 Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN)
D11073 Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN)
D00275 Cisplatin (JP17/USP/INN)
D01363 Carboplatin (JP17/USP/INN)
D01790 Oxaliplatin (JAN/USP/INN)
D00478 Procarbazine hydrochloride (JP17/USP)
D02994 Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN)
D03257 Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN)
D03455 Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN)
D06409 Bevacizumab (USAN); Bevacizumab (genetical recombination) (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN)
D05350 Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN)
D09314 Ofatumumab (USAN/INN); Ofatumumab (genetical recombination) (JAN)
D04603 Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN)
D09587 Brentuximab vedotin (USAN); Brentuximab vedotin (genetical recombination) (JAN)
D05446 Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN)
D09980 Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN)
D09321 Obinutuzumab (USAN); Obinutuzumab (genetical recombination) (JAN)
D10316 Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN)
D10574 Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN)
D09325 Blinatumomab (USAN/INN); Blinatumomab (genetical recombination) (JAN)
D09371 Ramucirumab (USAN); Ramucirumab (genetical recombination) (JAN)
D10018 Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN)
D09337 Elotuzumab (USAN); Elotuzumab (genetical recombination) (JAN)
D10777 Daratumumab (USAN); Daratumumab (genetical recombination) (JAN)
D09761 Mogamulizumab (USAN); Mogamulizumab (genetical recombination) (JAN)
D10808 Durvalumab (USAN/INN); Durvalumab (genetical recombination) (JAN)
D10817 Avelumab (USAN); Avelumab (genetical recombination) (JAN)
D10773 Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN)
D11050 Isatuximab (USAN/INN); Isatuximab (genetical recombination) (JAN)
D11529 Trastuzumab deruxtecan (USAN/INN); Trastuzumab deruxtecan (genetical recombination) (JAN)
D03106 Bexarotene (JAN/USAN/INN)
D03150 Bortezomib (JAN/USAN/INN)
D08880 Carfilzomib (JAN/USAN/INN)
D10131 Ixazomib citrate (JAN/USAN)
D06320 Vorinostat (JAN/USAN)
D06637 Romidepsin (JAN/USAN/INN)
D10019 Panobinostat lactate (JAN)
D09730 Olaparib (JAN/USAN/INN)
D11895 Niraparib tosilate hydrate (JAN)
D02997 Asparaginase (USAN); L-Asparaginase (JAN); Asparaginase Erwinia chrysanthemi (USAN)
D00155 Pentostatin (JAN/USAN/INN)
D02106 Arsenic trioxide (JP17/USAN)
D08914 Eribulin mesylate (USAN); Eribulin mesilate (JAN)
D10679 Venetoclax (JAN/USAN/INN)
D00966 Tamoxifen citrate (JP17/USP)
D00967 Toremifene citrate (JAN/USAN)
D01161 Fulvestrant (JAN/USP/INN)
D00586 Flutamide (JP17/USP/INN)
D00961 Bicalutamide (JAN/USP/INN)
D10218 Enzalutamide (JAN/USAN)
D11040 Apalutamide (JAN/INN)
D11045 Darolutamide (JAN/USAN/INN)
D00960 Anastrozole (JAN/USP/INN)
D00964 Letrozole (JAN/USP/INN)
D00963 Exemestane (JAN/USP/INN)
D09701 Abiraterone acetate (JAN/USP)
D00753 Sirolimus (JAN/USAN/INN)
D02802 Alemtuzumab (USAN/INN); Alemtuzumab (genetical recombination) (JAN)
D00754 Thalidomide (JAN/USP/INN)
D09813 Lenalidomide hydrate (JAN)
D08976 Pomalidomide (JAN/USAN/INN)
D04489 Ibritumomab tiuxetan (USAN/INN); Ibritumomab tiuxetan (genetical recombination) (JAN)
D10398 Radium Ra 223 dichloride (USAN)
D01404 Sobuzoxane (JAN)
D01416 Nedaplatin (JAN/INN)
D01418 Tamibarotene (JAN/INN)
D04245 Forodesine hydrochloride (JAN/USAN)
D06294 Miriplatin hydrate (JAN)
D10819 Aflibercept beta (genetical recombination) (JAN)
D11070 Tirabrutinib hydrochloride (JAN)
D11272 Borofalan (10B) (JAN)
D11805 Cetuximab sarotalocan sodium (genetical recombination) (JAN)
|
D08AX08 V03AB16 V03AZ01
D10AD01 L01XF01
L01BB04 L04AA40
L01BC07
L01CX01
L01DB07
L01EA01
L01EA02
L01EA03
L01EA04
L01EA05
L01EB01
L01EB02
L01EB03
L01EB04
L01EB07
L01EC01
L01EC02
L01EC03
L01ED01
L01ED02
L01ED03
L01ED05
L01EE01
L01EE03
L01EF01
L01EF03
L01EG01
L01EG02 L04AA18
L01EH01
L01EJ01
L01EK01
L01EL01
L01EX01
L01EX02
L01EX03
L01EX04
L01EX05
L01EX07
L01EX08
L01EX11
L01EX13
L01EX14
L01EX17
L01EX21
L01XA01
L01XA02
L01XA03
L01XB01
L01XC02
L01XC03
L01XC06
L01XC07
L01XC08
L01XC10
L01XC11
L01XC12
L01XC13
L01XC14
L01XC15
L01XC17
L01XC18
L01XC19
L01XC21
L01XC22
L01XC23
L01XC24
L01XC25
L01XC28
L01XC31
L01XC32
L01XC38
L01XC41
L01XF03
L01XG01
L01XG02
L01XG03
L01XH01
L01XH02
L01XH03
L01XK01
L01XK02
L01XX02
L01XX08
L01XX27
L01XX41
L01XX52
L02BA01
L02BA02
L02BA03
L02BB01
L02BB03
L02BB04
L02BB05
L02BB06
L02BG03
L02BG04
L02BG06
L02BX03
L04AA10 S01XA23
L04AA34
L04AX02
L04AX04
L04AX06
V10XX02
V10XX03
|
4299 Others
|
43 Radioactive drugs
|
44 Allergic agents
|
49 Other agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
6 Agents against pathologic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|